Genzyme's (GENZ) Quality Control Detects Foreign Particles in Five Enzyme Replacement Products; Issues Letters to U.S. Healthcare Providers
Tweet Send to a Friend
Genzyme Corp. (Nasdaq: GENZ) has issued letters to U.S. healthcare providers regarding its enzyme replacement products Cerezyme (imiglucerase for injection) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
